Litcius/Paper detail

Once-daily savolitinib in Chinese patients with pulmonary sarcomatoid carcinomas and other non-small-cell lung cancers harbouring MET exon 14 skipping alterations: a multicentre, single-arm, open-label, phase 2 study

Shun Lü, Jian Fang, Xingya Li, Lejie Cao, Jianying Zhou, Qisen Guo, Zongan Liang, Ying Cheng, Liyan Jiang, Nong Yang, Zhigang Han, Jianhua Shi, Yuan Chen, Hua Xu, Helong Zhang, Gongyan Chen, Rui Ma, Sanyuan Sun, Yun Fan, Jing Li, Xian Luo, Linfang Wang, Yongxin Ren, Weiguo Su

2021The Lancet Respiratory Medicine204 citationsDOI

Topics & Concepts

MedicineDiscontinuationClinical endpointInternal medicineProgressive diseaseLung cancerResponse Evaluation Criteria in Solid TumorsGastroenterologyCancerSurgeryOncologyClinical trialDiseaseMetastasis and carcinoma case studiesLung Cancer Treatments and MutationsCholangiocarcinoma and Gallbladder Cancer Studies